Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Pharmacogenetics and treatment response in schizophrenia].

L'Encephale - 1 Dec 2007

Moulier V, Januel D

Abstract excerpt

UNLABELLED: The pharmacogenetic strategy uses the genetic association approach with the aim of identifying genes that influence clinical response to drug treatment. Association studies have focused mainly on neuroleptics (in particular clozapine) and variants in candidate genes of dopamine and serotonin systems in schizophrenic patients. Concerning the serotonin 5-HT(2A) receptor gene, the frequency of allele...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Polymorphism, Genetic
Share to Receptor, Serotonin, 5-HT2A

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Receptors, Dopamine D3

Share to Receptors, Dopamine D4

Share to Schizophrenia

Source

Identifiers

PMID: 18789788
DOI: 10.1016/j.encep.2007.01.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Pharmacogenetics and treatment response in schizophrenia].PMID 18789788Read ↗

[Pharmacogenetics and tailored drug treatment in schizophrenia].Semantic proximity Read ↗

Pharmacogenetics of schizophrenia.Semantic proximity Read ↗

Genomics and the future of pharmacotherapy in psychiatrySemantic proximity Read ↗

Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients.Semantic proximity Read ↗

[Molecular pharmacogenetic study on antipsychotic-drug therapy responders with depression or schizophrenia].Semantic proximity Read ↗

Pharmacogenomics: a path to predictive medicine for schizophrenia.Semantic proximity Read ↗

Neurotransmitter receptor variants and their influence on antipsychotic treatment (Review)).Semantic proximity Read ↗

Pharmacogenomics of psychiatric drug treatment.Semantic proximity Read ↗

[Clinical pharmacogenetics in the treatment of schizophrenia].Semantic proximity Read ↗

[Clinical pharmacogenetics in the treatment of schizophrenia].Semantic proximity Read ↗

[Pharmacogenetic aspects of the dopaminergic system in clozapine pharmacodynamics].Semantic proximity Read ↗

Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspectsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.